Primary Citation PubMed: 19640844
Citations in PubMed
This linkout lists citations, indexed by PubMed, to the Primary Citation for this PDB ID.
Data mentions are occurrences of PDB IDs in the full text articles from the
PubMedCentral Open Access Subset
of currently about 1 million articles. For each article, the sentences containing the PDB ID are listed.
Article titles can be filtered by keywords and sorted by year.
PubMed ID is not available.
Published in 2014
Crystallographic phases were solved by molecular replacement using PDB ID 3I65( 15 ) and were refined to R and R free of 0.185 and 0.240, respectively.
Publication Year: 2014
Published in 2015
Structure-Based Modeling As a basis for structure-based pharmacophore modeling, we selected six PDB structures of bound DHODH (1TV5, 3I65, 3I68, 3I6R, 3O8A, 3SFK).
Receptor structure and binding site residues of 3I65 are shown in blue.
Pose alignments were obtained by aligning the crystal receptor with 3I65 using PyMOL [ 22 ].
Inhibitor-bound DHODH co-crystal PDB: 3I65 resulted in the best pharmacophore models, while the other co-crystals failed to consistently retrieve compound 6 among the hits.
g001 Fig 1 A pharmacophore derived by a student from a structure of DHODH bound to an inhibitor (PDB 3I65).
The initial model space considered for PDB: 3I65 consisted of six pharmacophores, which were rationally chosen based on the inhibitor chemistry and the chemical environment of the binding site.
Publication Year: 2015
RCSB PDB (citation) is managed by two members of the Research Collaboratory for Structural Bioinformatics: Rutgers and UCSD/SDSC
RCSB PDB is a member of the
The RCSB PDB is funded by a grant (DBI-1338415) from the
National Science Foundation, the
National Institutes of Health, and the
US Department of Energy.